HLB Science (XKRX:343090) Change In Payables And Accrued Expense : ₩0.00 Mil (TTM As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is HLB Science Change In Payables And Accrued Expense?

HLB Science's Change In Payables And Accrued Expense for the quarter that ended in . 20 was ₩0.00 Mil. It means HLB Science's Accounts Payable & Accrued Expense stayed the same from . 20 to . 20 .

HLB Science's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ₩0.00 Mil. It means HLB Science's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

HLB Science Change In Payables And Accrued Expense Historical Data

The historical data trend for HLB Science's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Change In Payables And Accrued Expense Chart

HLB Science Annual Data

Trend

Dec22

Dec23

Change In Payables And Accrued Expense

HLB Science Quarterly Data

Change In Payables And Accrued Expense

HLB Science Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0.00 Mil.

HLB Science Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of HLB Science's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science (XKRX:343090) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR

Website

http://www.hlbscience.com

HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines